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increasing of treatment cost and the aim of treatment 
toxicity control. Some studies described misuse of 
statistical tests in medical studies but also difficulties to 
understand biostatistics for most of medical doctor. Thus, 
medical school should develop statistical tests and data 
analysis lessons. Moreover, we are now into artificial 
intelligence era partially based on advanced statistical 
analysis and medical doctor should be aware of multiple 
existing biases to not be victim of non-accurate conclusion 
but also better interact with biostatical team. Here, we 
briefly explain how to use and ptifalls of most used tests 
such as Parametrical and non-parametrical tests, Kaplan 
Meier, Log Rank, Cox regression, Fine and Gray, Restricted 
Mean Survival and Classifier. 
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Abstract text 
In this session I will discuss how to acquire (and keep on 
having) a staff medical physicist position with dedicated 
and protected time for research. The first part of the talk 
is about the training to become a medical physicist. The 
training period is a period to decide in which direction you 
would like to develop yourself, gain relevant experience 
in different institutions, and making yourself seen among 
the medical physics community. The key for enhancing 
your visibility and increasing your attractiveness for 
institutes with combined medical physics and research 
positions, is research. I will present tips on how to achieve 
as much as possible with the limited time for research you 
may have during training. In the second part of the talk I 
will present the challenges and possible solutions of being 
a medical physicist with research time that sees his/her 
research time evaporate in the demanding and hectic 
environment called clinical practice.     
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Abstract text 
Radiation Oncologists are regularly confronted with a 
treatment of non-curative diseases. To improve their 
outcome  the development of new treatment 
strategies  will be necessary. Ideally more Radiation 
Oncologists should actively participate in relevant pre-
clinical  studies  designing further clinical trials based on 
their findings.  Realistically, this approach is challenging 
and difficult achievable due lack of ideas, facilities and 
financial support. In this presentation, possibilities to 
perform clinical and lab research during the training and 
afterwards in two  large European Health Systems 
(German and  British) will be elucidated. We can conclude 
that to retain motivated colleagues who want to actively 
participate in lab and clinical research projects, the 
appropriate length of time close to their routine clinical 
activities should be ensured.  
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Abstract text 
A head of department must be a true all-rounder in 
radiation oncology. In addition to the professional 
experience, the chief physician must show the economic 
competence, leadership, training and organizational skills 
that are necessary for the development of his department 
and its integration into a scientific network. In Germany, 
a large part of the radiation therapy is performed at 
outpatient centers. Thus, university hospitals and 
maximum care hospitals have a particular responsibility to 
contribute to education and research. In addition to 
continuously securing high standards of care on a daily 
basis, it is also necessary to establish sufficient staff 
resources to be able to carry out high quality scientific 
projects. 
Within the next two years, the Marien Hospital Siegen 
hospital together with three other regional hospitals will 
become a university hospital associated with a newly 
established medical school. Opportunities in the so called 
"Rethink Medicine" project include the economic 
cooperation of four hospitals within one city and the 
development of translational research projects in 
collaboration with international partners such as the 
Erasmus Medical Center Rotterdam (EMC) and the 
University of Oxford. One of the key challenges will be to 
establish basic and translational research programmes to 
complement the clinical research already taking place 
today. 
In this lecture, the mentioned points are reflected from 
the perspective of a young head of a department (35 years 
old) for radiation oncology in Germany. 
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Purpose or Objective 
The Inuit are one of three indigenous groups in Canada. 
Despite living in a high-income country (HIC), their unique 
sociodemographic characteristics mirrors those of low-
and-middle income countries (LMIC) in terms of cancer 
care and outcomes. Geography is an important barrier. 
Inuit cancer patients from the northern Arctic territory of 
Nunavut must fly significant distances to access 
radiotherapy (RT) in southern Canada. RT utilization 
(RTU), the proportion of patients receiving RT, is an 
essential step to create polices for designing affordable 
and equitable RT service, which is a critical, and complex 
component of better cancer outcomes. However, RTU has 
never been specifically studied among the Inuit. 
Material and Methods 
We conducted descriptive analyses comparing the cancer 
incidence among Nunavut’s largest health region 
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Purpose or Objective 
Planning for radiotherapy services requires evidence 
based information on the optimum and the actual use of 
this therapy in a population in order to assess the potential 
gaps in the utilization of external beam radiotherapy.  
The objective of this study was to assess the actual 
utilization of external beam radiotherapy in two 
population based cancer registries in Girona and Tarragon, 
Catalonia, Spain. In addition, problems of access due to 
distance between patients residence to radiotherapy 
departments were analysed. 
Material and Methods 
There are two cancer registries in Catalonia, Girona 
(750,000 inhabitants) and Tarragona (800,000 
inhabitants), in both cases only one Radiation oncology 
department is available in each health region. All incident 
cancer patients (with the exception of non-melanoma skin 
cancers) of both regions diagnosed during the years 2009-
2011 were linked to the reimbursement database of the 
Catalonian Health Care Service. We calculated the 
proportion of patients receiving a external radiotherapy 
treatment during the first year after the diagnosis of the 
cancer, by type of tumour. Only the first radiotherapy 
treatment was included in this analysis, even if they 
subsequently received a retreatment. 
Results 
The proportion of incident cases receiving radiotherapy 
treatment during the first year after diagnosis was 24.3%. 
The proportion of treatments decreased significantly at 
older ages (from 21.3% younger than 40 years old and 32% 
for 40-64 to 14.3% in patients older than 75 years). There 
were no differences in uptake of radiotherapy by distance 
from the residence of the patient to the Radiation 
oncology department.  
The tumour sites (all stages at diagnosis) with highest 
proportion of radiotherapy use in the first year after 
diagnosis were breast (58%), head and neck (42%), Rectum 
(41%), Prostate (33%) and lung (30%).  
Conclusion 
There is a significant gap between optimal use and actual 
use (although this study is focused on first year after 
diagnosis) and this is especially relevant in some tumour 
sites like bladder and haematological cancers. Population 
based data on actual use is an essential element for 
planning resources needed and it makes feasible to assess 
potential factors to explain the optimum-actual utilization 
gap and to reduce it when required to increase evidence 
based indications of radiation oncology.
